Stem Cell Exosomes (Research Product)
Research Tool
CommercialActive
Key Facts
About EriVan Bio
EriVan Bio is a private, pre-revenue biotech company developing exosome-based research tools and therapeutic candidates. The company offers a portfolio of exosomes derived from adipose stem cells, bovine milk, and human plasma for research and biopharmaceutical manufacturing. With a leadership team combining scientific and entrepreneurial expertise, EriVan aims to advance exosome technology for targeted drug delivery, particularly in oncology, and diagnostics. Its foundation stems from award-winning academic research on miRNAs and extracellular vesicles.
View full company profileTherapeutic Areas
Other Research Tool Drugs
| Drug | Company | Phase |
|---|---|---|
| Single-Molecule RNA Imaging Fluorophores | Lucerna | Development |
| Bovine Milk Exosomes (Research Product) | EriVan Bio | Commercial |
| Human Plasma Exosomes (Research Product) | EriVan Bio | Commercial |
| Oligonucleotide Synthesis Service | Microsynth | Commercial |
| Single-Cell Transcriptomics Service | Systasy Bioscience | Service |